Clinical Trial Update: HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating HSV-tk gene therapy with valacyclovir and SBRT plus chemotherapy for recurrent glioblastoma and anaplastic astrocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• HSV-tk (herpes simplex virus thymidine kinase)
• Valacyclovir (Valacyclovir)

Snippet

Sponsor: David Baskin MD | Conditions: Glioblastoma Multiforme, Astrocytoma, Grade III | Phase 1, Phase 2 | Status: RECRUITING